FIELD: chemistry.
SUBSTANCE: claimed invention relates to application of compounds of general formula I where R1=H, CH3CO, C2H5CO, CH2=CHCO, CH2=C(CH3)CO, C6H5CO, m-FC6H4CO, m-ClC6H4CO, BrC11H22CO. R2=CH3, C2H5, n-C3H7, i-C3H7, C4H9, C4H8F, C2H4F, C2H4OH, CH2=CH-CH2-, CH2-CH-CH2 X=Cl, Br, I, dialkylphosphate, methane sulfonate, as hypotensive medication. In duration of hypertensive action proposed substances exceed mesatone and other medications, applied in medical practice for hypotensive condition treatment. Also described is pharmacological composition, based on formula I compounds.
EFFECT: obtaining of medication, which in duration of action exceeds mesatone and other medications, applied in medical practice for hypotensive condition treatment.
3 cl, 4 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIHYPOTONIC AGENT | 2011 |
|
RU2506082C2 |
ANTIANTIHYPERTENSIVE | 2007 |
|
RU2338538C1 |
VASOPRESSOR AGENT | 2013 |
|
RU2552529C1 |
VASOCONSTRICTOR | 2011 |
|
RU2475479C1 |
METHOD FOR PREMEDICATION IN PATIENTS WITH A LOCAL KIDNEY CANCER WITH ARTERIAL HYPERTENSION CONTROLLED BY ANGIOTENSINE TRANSFORMING ENZYME INHIBITORS | 2018 |
|
RU2681496C1 |
METHOD OF SHOCK TREATMENT | 1989 |
|
RU2012333C1 |
AGENT EFFECTING ON ARTERIAL PRESSURE | 1997 |
|
RU2187309C2 |
MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
MEDICINAL ANTISHOCK AGENT | 1996 |
|
RU2142796C1 |
ANTICANCER AGENT | 2012 |
|
RU2503450C1 |
Authors
Dates
2009-04-27—Published
2007-11-06—Filed